February 28, 2023: Biosimilars and Domperidone Read Now Summary/Highlights Saskatchewan Biosimilars Initiative Support tools for pharmacists: A-PAR, Insulin Glargine and Insulin Aspart Comparison Charts, and the Transitioning to a Biosimilar Insulin infographic Register to receive the recording from the biosimilar insulin webinar Live biosimilar Q&A: March 8th, 2023 Professional Practice Domperidone Use in Breastfeeding/Chestfeeding: health care professional handout and patient handout Need to Know Information about Norovirus From the medSask database A question from the lines: Alternatives to valproic acid capsules during drug shortage
Am J Epidemiol
Plant Cell Physiol 25:385395 Iqbal A, Yabuta Y, Takeda T, Nakano Y, Shigeoka S (2006) Hydroperoxide reduction by thioredoxin-specific glutathione peroxidase isoenzymes of Arabidopsis thaliana
Achieving this vision will require interdisciplinary collaboration, standardized transformation protocols, and clear regulatory frameworks for edible genetically engineered fungi
High drug costs may limit accessibility and widen existing health disparities, particularly among underserved populations
Ultimately, the key takeaway is that patients with sulfa allergies should not be overly concerned about taking semaglutide, but it is always a good idea to stay informed and communicate openly with healthcare providers about any worries